Unknown

Dataset Information

0

First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults.


ABSTRACT: BACKGROUND:National guidelines make recommendations regarding the initial opioid prescriptions, but most of the supporting evidence is from the initial episode of care, not the first prescription. OBJECTIVE:To examine associations between features of the first opioid prescription and high-risk opioid use in the 18 months following the first prescription. DESIGN:Retrospective cohort study using data from a large commercial insurance claims database for 2011-2014 to identify individuals with no recent use of opioids and follow them for 18 months after the first opioid prescription. PARTICIPANTS:Privately insured patients aged 18-64 and Medicare Advantage patients aged 65 or older who filled a first opioid prescription between 07/01/2011 and 06/30/2013. MAIN OUTCOMES AND MEASURES:High-risk opioid use was measured by having (1) opioid prescriptions overlapping for 7 days or more, (2) opioid and benzodiazepine prescriptions overlapping for 7 days or more, (3) three or more prescribers of opioids, and (4) a daily dosage exceeding 120 morphine milligram equivalents, in each of the six quarters following the first prescription. KEY RESULTS:All three features of the first prescription were strongly associated with high-risk use. For example, among privately insured patients, receiving a long- (vs. short-) acting first opioid was associated with a 16.9-percentage-point increase (95% CI, 14.3-19.5), a daily MME of 50 or more (vs. less than 30) was associated with a 12.5-percentage-point increase (95% CI, 12.1-12.9), and a supply exceeding 7 days (vs. 3 or fewer days) was associated with a 4.8-percentage-point increase (95% CI, 4.5-5.2), in the probability of having a daily dosage of 120 MMEs or more in the long term, compared to a sample mean of 4.2%. Results for the Medicare Advantage patients were similar. CONCLUSIONS:Long-acting formulation, high daily dosage, and longer duration of the first opioid prescription were each associated with increased high-risk use of opioids in the long term.

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC6258623 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults.

Zhang Yongkang Y   Johnson Phyllis P   Jeng Philip J PJ   Reid M Carrington MC   Witkin Lisa R LR   Schackman Bruce R BR   Ancker Jessica S JS   Bao Yuhua Y  

Journal of general internal medicine 20180911 12


<h4>Background</h4>National guidelines make recommendations regarding the initial opioid prescriptions, but most of the supporting evidence is from the initial episode of care, not the first prescription.<h4>Objective</h4>To examine associations between features of the first opioid prescription and high-risk opioid use in the 18 months following the first prescription.<h4>Design</h4>Retrospective cohort study using data from a large commercial insurance claims database for 2011-2014 to identify  ...[more]

Similar Datasets

| S-EPMC6582995 | biostudies-literature
| S-EPMC6935869 | biostudies-literature
| S-EPMC7181702 | biostudies-literature
| S-EPMC8063062 | biostudies-literature
| S-EPMC5524743 | biostudies-other
| S-EPMC6481953 | biostudies-literature
| S-EPMC7856043 | biostudies-literature